Haemonetics (HAE) Misses Q4 EPS by 9c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $86.22 --0%
Revenue Growth %: +8.4%
Financial Fact:
Net income: 0.38
Today's EPS Names:
UXIN, TOWN, NRIM, More
Revenue Growth %: +8.4%
Financial Fact:
Net income: 0.38
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.37, $0.09 worse than the analyst estimate of $0.46. Revenue for the quarter came in at $243.2 million versus the consensus estimate of $245.08 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- ESSA Bancorp (ESSA) Tops Q2 EPS by 13c
- VIST Financial Corp. (VIST) Misses Q1 EPS by 19c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
